Death Receptor-3, a New E-Selectin Counter-Receptor that Confers Migration and Survival Advantages to Colon Carcinoma Cells by Triggering p38 and ERK MAPK Activation

Stéphanie Gout(Institut pour l'avancée des biosciences), Jacques Huot(Université Laval)
Cancer Research
September 15, 2006
Cited by 102


Related Papers